Terms: = Colorectal cancer AND NFATC2, ENSG00000101096, 4773, Q13469, NFATP, NFAT1, KIAA0611 AND Treatment
4 results:
1. Hybrid abdominal robotic approach with conventional transanal total mesorectal excision (TaTME) for rectal cancer: feasibility and outcomes from a single institution.
Nikolic A; Waters PS; Peacock O; Choi CC; Rajkomar A; Heriot AG; Smart P; Warrier S
J Robot Surg; 2020 Aug; 14(4):633-641. PubMed ID: 31625075
[TBL] [Abstract] [Full Text] [Related]
2. Inhibitory ASIC2-mediated calcineurin/NFAT against colorectal cancer by triterpenoids extracted from Rhus chinensis Mill.
Wang G; Wang YZ; Yu Y; Wang JJ
J Ethnopharmacol; 2019 May; 235():255-267. PubMed ID: 30772482
[TBL] [Abstract] [Full Text] [Related]
3. Rehabilitation of fecal incontinence after sphincter-saving surgery for rectal cancer: encouraging results.
Pucciani F; Ringressi MN; Redditi S; Masi A; Giani I
Dis Colon Rectum; 2008 Oct; 51(10):1552-8. PubMed ID: 18452041
[TBL] [Abstract] [Full Text] [Related]
4. Expression and function of the nuclear factor of activated T cells in colon carcinoma cells: involvement in the regulation of cyclooxygenase-2.
Duque J; Fresno M; Iñiguez MA
J Biol Chem; 2005 Mar; 280(10):8686-93. PubMed ID: 15632146
[TBL] [Abstract] [Full Text] [Related]
